LEBECETIN, A C-TYPE LECTIN, AS NEOVASCULARIZATION INHIBITOR

• 收藏
• 分享

专利权人:

INSTITUT PASTEUR DE TUNIS;CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE;INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE);SORBONNE UNIVERSITE

发明人:

XAVIER GUILLONNEAU,FADOUA MONTASSAR,NAZIHA MARRAKCHI,ERIJ MESSADI,FLORIAN SENNLAUB,JOSÉ-ALAIN SAHEL

申请号：

US16468305

公开号：

US20190298797A1

申请日:

2017.12.12

申请国别(地区):

US

年份:

2019

代理人:

摘要：

The present invention relates to lebecetin, a functional variant or fragment thereof, for use as neovascularization inhibitor, in particular in the treatment of neovascular diseases such as ocular diseases, cancers or inflammatory disorders with a neovascular component.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/